Knowell Pharma Solutions Llp - Due diligence report

A 360° intelligence report on Knowell Pharma Solutions Llp: trust score, financial health, credit view, compliance, directors, growth and di…

2010-05-06 Delhi, Delhi Active
Share
View plans
KP Knowell Pharma Solutions Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Knowell Pharma Solutions Llp — 360° Intelligence Report

Generated from MCA filings & public records
91/100
Trust Score
Low Risk

Knowell Pharma Solutions Llp is assessed as Low Risk with a Trust Score of 91/100. Knowell Pharma Solutions Llp is an active limited liability partnership incorporated in 2010, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 29 Jun 2026 from the latest processed filings. Knowell Pharma Solutions Llp snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
91/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Profitable - internal accruals available.

Charges position: 5 open (16.47 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Housing Development Finance Corporation Limited2 48.0 cr
Union Bank Of India1 48.0 cr
The Hongkong And Shanghai Banking Corporation Limited1 48.0 cr
Hdfc Bank Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 2 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
KARAN ANAND 01234567 Director 01/04/2018 6 yrs Approved
SUNIL ANAND 01234567 Director 01/04/2018 6 yrs Approved
VARUN ANAND 01234567 Director 01/04/2018 6 yrs Approved
KANIKA ANAND 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
Operating for 16+ years.
Active GST registration(s).
Distress signals & risk flags
5 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence94/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment77/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 16.47 cr already registered.
  • Compliance record supports lending.
Investor view87/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Jun 2025
Charge created
Union Bank Of India - 4.95 cr
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
08 Dec 2022
Charge created
Hdfc Bank Limited - 1.20 cr
28 Sep 2022
Charge created
The Hongkong And Shanghai Banking Corporation Limited - 4.00 cr
30 Jul 2022
Charge created
Housing Development Finance Corporation Limited - 2.80 cr
Charge created
Housing Development Finance Corporation Limited - 3.52 cr
10 Jan 2019
Director appointed
KARAN ANAND (Designated Partner)
Director appointed
SUNIL ANAND (Designated Partner)
Director ceased
SIDDHARTH JANI
06 May 2010
Incorporated
Registered with Roc Delhi
Director appointed
VARUN ANAND (Designated Partner)
Director appointed
KANIKA ANAND (Designated Partner)
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Excel Biolife Private Limited U67120MH2000PTC124165 Mumbai, Maharashtra, India
Mcneil & Argus Pharmaceuticals U24231HR1988PLC030217 Haryana, Haryana, India
Uttar Pradesh Medical Supplies Corporation Limited U85310UP2018SGC102425 Lucknow, Uttar Pradesh, India
Imperia Life Sciences Private Limited U45100GJ2013PTC120767 Vadodara, Gujarat, India
Vovantis Laboratories Private Limited U24230GJ2008PTC055176 Vadodara, Gujarat, India
Lok-Beta Pharmaceuticals (India )Private Limited U24230MH2002PTC135577 Mumbai, Maharashtra, India
Dr. Reddy’S Laboratories U67120TG1994PLC017906 A.P., Telangana, India
Aurochem Laboratories (India) Private Limited U24230MH1997PTC112098 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Knowell Pharma Solutions Llp before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Knowell Pharma Solutions Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Knowell Pharma Solutions Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 91/100, distress signals and MSME payment-delay disclosures - know whether Knowell Pharma Solutions Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Knowell Pharma Solutions Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Knowell Pharma Solutions Llp an active company?

Knowell Pharma Solutions Llp has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Knowell Pharma Solutions Llp financially healthy?

Knowell Pharma Solutions Llp has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Knowell Pharma Solutions Llp?

Its overall Trust Score is 91/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Knowell Pharma Solutions Llp?

See the directors and ownership sections above for board and shareholding detail. 4 active director(s) are on record.

Does Knowell Pharma Solutions Llp have loans or charges against its assets?

5 open charge(s) are registered against its assets.

Is Knowell Pharma Solutions Llp up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Knowell Pharma Solutions Llp?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.